MDT vs BSX
MDT and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MDTMedtronic plc | BSXBOSTON SCIENTIFIC CORPORATION |
|---|---|---|
| Market cap | $123.51B | $60.82B |
| P/E (TTM) | 23.8 | 17.0 |
| P/B | 2.46 | 2.44 |
| P/S | 3.4x | 3.0x |
| Dividend yield | 2.95% | — |
| Revenue | $37.54B(TTM) | $21.00B(TTM) |
| Revenue growth (YoY) | 8.4% | 19.9% |
| Net income | $430.00M(TTM) | $3.67B(TTM) |
| Earnings growth (YoY) | 3.0% | 56.7% |
| EPS, diluted | $4.06(TTM) | $2.47(TTM) |
| EBIT margin | 17.8% | 18.0% |
| ROE | 0.0% | 11.6% |
| ROIC | 7.0% | 10.0% |
| Piotroski F | 8/9 | 8/9 |
| 1y total return | +9.3% | -58.3% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: MDT vs BSX
| Metric | MDT | BSX |
|---|---|---|
| End value | $14.5K | $18.2K |
| Total return | +45.4% | +82.3% |
| CAGR | +3.7% | +6.0% |
| Volatility | 23.4% | 27.5% |
| Sharpe | 0.09 | 0.20 |
| Sortino | 0.13 | 0.27 |
| Max drawdown | -45.3% | -61.5% |
Based on 2600 common trading days, 2016-06-29 → 2026-10-30 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)